More NewsRead More
Trevena to present at the 18th Annual BIO CEO & Investor Conference
February 03, 2016
Trevena, Inc. Announces Initiation of Oliceridine Phase 3 Clinical Program With Multi-Procedure Safety and Tolerability Study
January 19, 2016
Trevena, Inc. added to NASDAQ Biotechnology Index (NBI)
December 16, 2015
Direction of Market Influences - Research on DHI Group, Trevena, Spectrum Pharmaceuticals and Douglas Dynamics
November 19, 2015
category Business & Professional Services
Trevena Announces FDA Grant of Fast Track Designation to Oliceridine (TRV130) for the Management of Moderate-to-Severe Acute Pain
December 03, 2015
from Market News Video
from Dividend Channel
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here